TY - JOUR
T1 - Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment
AU - Maresca, Rossella
AU - Varca, Simone
AU - Di Vincenzo, Federica
AU - Ainora, Maria Elena
AU - Mignini, Irene
AU - Papa, Alfredo
AU - Scaldaferri, Franco
AU - Gasbarrini, Antonio
AU - Giustiniani, Maria Cristina
AU - Zocco, Maria Assunta
AU - Laterza, Lucrezia
PY - 2024
Y1 - 2024
N2 - CMV infection is still a matter of concern in IBD patients, especially regarding the disease's relapse management. Why IBD patients, particularly those affected by ulcerative colitis, are more susceptible to CMV reactivation is not totally explained, although a weakened immune system could be the reason. Various techniques, ranging from serology to histology, can be employed to detect intestinal CMV infection; however, there is currently disagreement in the literature regarding the most effective diagnostic test. Furthermore, CMV involvement in steroid resistance has been broadly discussed, but whether CMV infection is a cause or consequence of the disease severity and, consequently, steroid refractoriness is still debated. Its potential contribution to the lack of response to advanced therapy and small molecules must be more valued and wholly explored. In this review, we look at the actual literature on CMV in IBD patients, and we suggest a pragmatic algorithm for clinical practice management of CMV infection.
AB - CMV infection is still a matter of concern in IBD patients, especially regarding the disease's relapse management. Why IBD patients, particularly those affected by ulcerative colitis, are more susceptible to CMV reactivation is not totally explained, although a weakened immune system could be the reason. Various techniques, ranging from serology to histology, can be employed to detect intestinal CMV infection; however, there is currently disagreement in the literature regarding the most effective diagnostic test. Furthermore, CMV involvement in steroid resistance has been broadly discussed, but whether CMV infection is a cause or consequence of the disease severity and, consequently, steroid refractoriness is still debated. Its potential contribution to the lack of response to advanced therapy and small molecules must be more valued and wholly explored. In this review, we look at the actual literature on CMV in IBD patients, and we suggest a pragmatic algorithm for clinical practice management of CMV infection.
KW - CMV
KW - Crohn’s
KW - IBD
KW - infections
KW - ulcerative colitis
KW - CMV
KW - Crohn’s
KW - IBD
KW - infections
KW - ulcerative colitis
UR - https://publicatt.unicatt.it/handle/10807/268445
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85181937822&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85181937822&origin=inward
U2 - 10.3390/jcm13010130
DO - 10.3390/jcm13010130
M3 - Article
SN - 2077-0383
VL - 13
SP - N/A-N/A
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 1
ER -